跳至主要内容
临床试验/NCT04385680
NCT04385680已完成1 期

The Impact of Chlorhexidine Preoperative Vaginal Preparation in Reducing the Post-cesarean Endometritis and Sepsis for Cases in Labor. A Randomized Controlled Trial

Zagazig University1 个研究点 分布在 1 个国家目标入组 840 人开始时间: 2020年5月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
840
试验地点
1
主要终点
post-cesarean endometritis

研究概览

简要总结

The study aims to assess the beneficial value of vaginal preparation with chlorhexidine gluconate 0.05% before cesarean delivery of cases in labor in reduction of postoperative endometritis, fever and wound complications compared to no preparation or using saline only.

详细描述

Despite the demonstrated effectiveness of the vaginal cleansing in the previous study, yet this has not been adopted within obstetric practice internationally and does not feature within the NICE Intrapartum guideline.7 This is may be due to concerns with exposure of the fetus to iodine-based substances, concerns with vaginal staining and allergy to iodine. Iodine is an antibacterial agent, but becomes inactive by the presence of blood may limit its use.

Chlorhexidine show greater reduction in skin flora after application compared with povidone-iodine agents (0.5 and 4%) respectively and has a greater residual activity after application than other preparations and (unlike povidone iodine) it is not inactivated by the presence of blood. Thus, there are a number of reasons to believe that vaginal cleansing with chlorhexidine would be an appropriate alternative to povidone iodine.8 There is one RCT comparing povidone iodine with chlorhexidine gluconate for vaginal cleansing at CS. This suggested that chlorhexidine may be superior, and further research was needed.9 Solutions that contain lower concentrations, such as chlorhexidine gluconate and acetate (0.05%) are usually well tolerated and may be used for vaginal preparation. With this preparation, there are no reported cases of allergy.8 Importantly, no safety concerns for the mother or baby have been identified with chlorhexidine gluconate used for vaginal cleansing.10

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Gestational age ≥28 weeks.
  • Cases had cesarean section after start of labor.

排除标准

  • Women with known allergy to chlorhexidine gluconate or any of its ingredients.
  • Women with diagnosed group B streptococcus (GBS) colonization.
  • Women with active infection during the procedure.
  • Women did not receive the standard preoperative antibiotic prophylaxis.
  • Women with diagnosis of chorioamnionitis.
  • Prolonged rupture of membranes >7 days

研究组 & 干预措施

Chlorhexidine vaginal prep.arm

Experimental

Women in labor who will receive vaginal cleaning immediately before cesarean section using 50 ml of chlorhexidine gluconate 0.05% solution and standard abdominal scrub with chlorhexidine gluconate 4%. This concentration is indicated within the British National Formulary for swabbing in obstetrics. A swab soaked in the antiseptic will be used to clean the vagina for 30 seconds prior to CS at the time of urinary catheter insertion by long forceps.

After the CS procedure, the vagina is always cleaned of excess blood as with a dry swab.

干预措施: Chlorhexidine Gluconate vaginal solution 0.05% (Drug)

结局指标

主要结局

post-cesarean endometritis

时间窗: First 10 days post-cesarean

uterine fundal tenderness on bimanual examination ( physical examination: suprapubic tenderness, pain elicited by cervical motion, tenderness in parametrium, all during bimanual examination) + with fever (An oral temperature of 38°C or higher within the first 10 days postpartum or 38.7°C within the first 24 hours postpartum) ± purulent lochia requiring antibiotic therapy ( initial antibiotic will be started then waiting for proper therapy according to culture and sensitivity

Postoperative wound infection

时间窗: First month after cesarean

erythema, warmth, tenderness, purulent drainage from the incision site, with or without fever, requiring antibiotic therapy.

次要结局

  • Chlorhexidine adverse drug reaction(First 10 days)
  • incidence of hospital readmission(One month)
  • Significant leukocytosis(First 10 days postcesarean)
  • length of hospital stay(One month)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Hytham Atia

Associate Professor Obstetrics & Gynecology

Zagazig University

研究点 (1)

Loading locations...

相似试验